Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells

作者: Yong Yang , Joy Wolfram , Kathryn Boom , Xiaohong Fang , Haifa Shen

DOI: 10.1002/CBF.2905

关键词: HesperidinBiologyGlucose Transporter Type 1EndocrinologyGLUT4HesperetinGlucose transporterGLUT1Internal medicineGlucose uptakeProtein kinase B

摘要: The flavanone hesperetin is known to decrease basal glucose uptake, although the inhibitory mechanism largely unknown. Here, we used MDA-MB-231 breast cancer cells investigate molecular pathways affected by hesperetin. results indicate that suppression of uptake caused down-regulation transporter 1 (GLUT1). Hesperetin was also found inhibit insulin-induced through impaired cell membrane translocation 4 (GLUT4). In addition, phosphorylation insulin receptor-beta subunit (IR-beta) and Akt suppressed. decreased cellular proliferation, which likely due inhibition uptake. Cancer are highly dependent on may, therefore, have potential application as an anticancer agent.

参考文章(48)
Rodolfo Laucirica, D. R. Mody, M. Younes, R. W. Brown, L. Fernandez, GLUT1 expression in human breast carcinoma: Correlation with known prognostic markers Anticancer Research. ,vol. 15, pp. 2895- 2898 ,(1995)
Joseph M. Muretta, Cynthia Corley Mastick, Chapter 10 How Insulin Regulates Glucose Transport in Adipocytes Vitamins and Hormones Series. ,vol. 80, pp. 245- 286 ,(2009) , 10.1016/S0083-6729(08)00610-9
Walter Brand, Berend Oosterhuis, Peter Krajcsi, Denis Barron, Fabiola Dionisi, Peter J. Bladeren, Ivonne M. C. M. Rietjens, Gary Williamson, Interaction of hesperetin glucuronide conjugates with human BCRP, MRP2 and MRP3 as detected in membrane vesicles of overexpressing baculovirus-infected Sf9 cells Biopharmaceutics & Drug Disposition. ,vol. 32, pp. 530- 535 ,(2011) , 10.1002/BDD.780
Mie Okumura, Mayumi Yamamoto, Hiroya Sakuma, Toshihiro Kojima, Takako Maruyama, Marjan Jamali, Denise R Cooper, Keigo Yasuda, Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-α and PPAR expression Biochimica et Biophysica Acta. ,vol. 1592, pp. 107- 116 ,(2002) , 10.1016/S0167-4889(02)00276-8
Jacobus N. Verhagen, Margreet C. M. Van Der Heijden, Gert Rijksen, Paul J. Der Kinderen, Jan A. M. Van Unnik, Gerard E. J. Staal, Determination and characterization of hexokinase in thyroid cancer and benign neoplasms. Cancer. ,vol. 55, pp. 1519- 1524 ,(1985) , 10.1002/1097-0142(19850401)55:7<1519::AID-CNCR2820550718>3.0.CO;2-K
Maria L. Macheda, Suzanne Rogers, James D. Best, Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer Journal of Cellular Physiology. ,vol. 202, pp. 654- 662 ,(2005) , 10.1002/JCP.20166
Raya S. Brown, Tonya M. Goodman, Kenneth R. Zasadny, Joel K. Greenson, Richard L. Wahl, Expression of hexokinase II and Glut-1 in untreated human breast cancer. Nuclear Medicine and Biology. ,vol. 29, pp. 443- 453 ,(2002) , 10.1016/S0969-8051(02)00288-3
Alejandro Godoy, Viviana Ulloa, Federico Rodríguez, Karin Reinicke, Alejandro J Yañez, María de los Angeles García, Rodolfo A Medina, Mónica Carrasco, Sofía Barberis, Tamara Castro, Fernando Martínez, Ximena Koch, Juan Carlos Vera, María Teresa Poblete, Carlos D Figueroa, Bruno Peruzzo, Fernando Pérez, Francisco Nualart, None, Differential subcellular distribution of glucose transporters GLUT1–6 and GLUT9 in human cancer: Ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues Journal of Cellular Physiology. ,vol. 207, pp. 614- 627 ,(2006) , 10.1002/JCP.20606